| Product Information |
BR-1366-PI_01.pdf
|
| Registration Number |
BR-1366
|
| Generic Name |
Durvalumab
|
| Brand Name |
Imfinzi
|
| Dosage Strength |
500 mg/10 mL (50 mg/mL)
|
| Dosage Form |
Cocentrate for Solution for IV Infusion
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
-
|
| Packaging |
10 mL Type I glass vial with chlorobutyl rubber
stopper and a white flip-off aluminum seal (Box of 1's)
|
| Manufacturer |
Catalent Indiana, LLC
|
| Country of Origin |
United States of America
|
| Trader |
|
| Importer |
AstraZeneca Pharmaceuticals (Phils.), Inc.
|
| Distributor |
AstraZeneca Pharmaceuticals (Phils.), Inc.
|
| Application Type |
Monitored Release (MR)
|
| Issuance Date |
07 September 2021
|
| Expiry Date |
07 September 2024
|